Hematology Information Center

Hematology Information Center

Hematopoietic Stem Cell Transplantation May Not Reduce Renal Function in Sickle Cell Disease

By

Lauren Dembeck, PhD

Publish Date December 29, 2020

For patients with sickle cell disease, HSCT may not be associated with a significant increase in CKD incidence or prevalence following transplantation.

Hematology Information Center

Iron Deficiency Anemia: Vitamin C Supplementation May Not Be Necessary

By

Jonathan Goodman, MPhil

Publish Date December 8, 2020

For patients with iron deficiency anemia, oral iron supplementation use alone is comparable to oral supplementation with vitamin C.

Infectious Diseases Information Center

High-Dose Anticoagulation May Not Aid COVID-19 Patients

Publish Date December 2, 2020

Higher doses of blood thinners are potentially harmful and have no clear benefits for hospitalized COVID-19 patients.

Hematology Information Center

ASH 2020 Guidelines on Venous Thromboembolism Management

By

Tori Rodriquez, MA, LPC, AHC

Publish Date November 27, 2020

The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.

Hematology Information Center

Serum Antiphospholipid, Phospholipid-Binding Protein Antibodies in Coronavirus Disease 2019

By

Vicki Moore, PhD

Publish Date November 25, 2020

Prothrombotic autoantibodies, similar to those with antiphospholipid syndrome, appear to be elevated in hospitalized patients with COVID-19.

Practice Management Information Center

Top October 2020 FDA Approvals

By

Michelle Lampariello

Publish Date November 17, 2020

The FDA has approved therapies for the treatment of COVID-19, leukemia, Ebola, and pediatric adrenocortical insufficiency in October 2020.

Hematology Information Center

Individuals With Blood Group O Have Lower Risk for COVID-19

Publish Date October 21, 2020

Compared with patients with blood group O or B, a higher proportion of COVID-19 patients with blood group A or AB required mechanical ventilation and continuous renal replacement therapy.

Neurology Information Center

Study Evaluates Plasma Biomarkers for Sports-Related Concussion

By

Madeline Morr

Publish Date October 16, 2020

Researchers conducted a study to examine whether plasma biomarkers can differentiate collegiate athletes who return to sports participation in less than 14 days or 14 days or more following a sports-related concussion.

Infectious Diseases Information Center

Factor V Activity Associated With Clinical Outcomes in Severe COVID-19

By

Lauren Dembeck, PhD

Publish Date October 1, 2020

Investigators assess underlying mechanisms and relevant biomarkers of morbidity and mortality due to coagulopathy in patients with severe COVID-19 infection.

Oncology Information Center

COVID-19, SARS-CoV-2 Infection Phenotypes Vary With Different Tumor Subtypes

By

Rita Aghjayan

Publish Date September 29, 2020

Among patients with cancer, tumor subtypes may influence varying susceptibility to SARS-CoV-2 and COVID-19 disease phenotypes.

Hematology Information Center

2021 Update on Diagnosis, Risk Stratification, and Management of Cutaneous B-Cell Lymphomas

By

Rita Aghjayan

Publish Date September 21, 2020

Researchers assessed diagnosis, risk-stratification, and management of 3 distinct subgroups of primary cutaneous lymphomas.

Hematology Information Center

Understanding the Association Between COVID-19, Thromboembolism, and Therapeutic Anticoagulation

By

Rita Aghjayan

Publish Date September 18, 2020

In expanded research, investigators studied the effects of therapeutic and prophylactic anticoagulation treatment in hospitalized patients with COVID-19.

Infectious Diseases Information Center

Prevalence of Endotheliopathy in COVID-19–Associated Coagulopathy

By

Lauren Dembeck, PhD

Publish Date August 20, 2020

A team of investigators sought to determine whether endotheliopathy is involved in COVID-19–associated coagulopathy pathogenesis.

Infectious Diseases Information Center

Convalescent Plasma Efficacious for Severe COVID-19

Publish Date August 20, 2020

Researchers from the Houston Methodist Hospital examined the efficacy of COVID-19 convalescent plasma transfusion vs standard of care.

Endocrinology Information Center

COVID-19 May Increase VTE Risk in Pregnant Women, Individuals Taking Estrogen Therapy

By

Brandon May

Publish Date August 12, 2020

Several questions remain regarding the effect of COVID-19 infection and hypercoagulation in the management of patients taking oral contraceptives, estrogen therapy, and patients who are pregnant.

Hematology Information Center

How Has the COVID-19 Pandemic Affected Blood Transfusion Supply, Use?

By

Rita Aghjayan

Publish Date July 23, 2020

Due to the COVID-19 pandemic, patterns of blood transfusion demands are not certain; therefore, institutions should plan for a reduction in donations.

Rheumatology Information Center

PRIME Cells Identified in Blood Before Flare in Rheumatoid Arthritis

Publish Date July 20, 2020

Distinct RNA signatures are evident in peripheral blood of rheumatoid arthritis patients before a disease flare.

Hematology Information Center

Thrombosis and Iron Deficient Anemia: Determining Trends in Thrombotic Complications

By

Lauren Dembeck, PhD

Publish Date July 17, 2020

Although the association between thrombocytosis in iron deficiency anemia is understood, researchers studied the risk for thrombotic complications.

Hematology Information Center

Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19

By

Rita Aghjayan

Publish Date June 29, 2020

Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.

Oncology Information Center

Close Monitoring, Full-Time Caregiver Recommended for 30 Days After CAR-T Therapy

By

Joyce Pagan

Publish Date June 19, 2020

Readmissions for CRS, neurotoxicity, infection, and other adverse events are common after immunotherapy with axicabtagene ciloleucel.